Welcure Drugs & Pharmaceuticals Limited

Equities

WELCURE6

INE331C01017

Pharmaceuticals

Delayed Bombay S.E. 12:15:00 03/06/2024 pm IST 5-day change 1st Jan Change
4.52 INR -4.84% Intraday chart for Welcure Drugs & Pharmaceuticals Limited -11.55% +17.40%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024 CI
Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO MT
Welcure Drugs & Pharmaceuticals Limited Announces Board Resignations CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Vishal Mehra as Chief Financial Officer CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mr. Vishal Mehra as Managing Director CI
Welcure Drugs & Pharmaceuticals Limited Approves Executive Changes CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Managing Director CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Chief Financial Officer CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Welcure Drugs & Pharmaceuticals Limited Approves the Shifting of the Registered Office CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Welcure Drugs & Pharmaceuticals Limited Announces Change of Address CI
Welcure Drugs & Pharmaceuticals Limited Approves Board Changes CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mayank Bhandari as Non Executive and Independent Director CI
Welcure Drugs & Pharmaceuticals Limited Announces Executive Changes CI
Welcure Drugs & Pharmaceuticals Limited Approves Shifting of Registered Office Within the Local Limits of City of Delhi CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mitashi Bisaria as Company Secretary / Compliance Officer, Effective October 8, 2022 CI
Welcure Drugs & Pharmaceuticals Limited Announces Director Resignations, with Effect from October 8, 2022 CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Sudhir Chandra as Managing Director, with Effect from October 8, 2022 CI
Welcure Drugs & Pharmaceuticals Limited Announces Change in Registered Office Address CI
Welcure Drugs & Pharmaceuticals Limited Announces Chief Financial Officer Changes CI
Welcure Drugs & Pharmaceuticals Limited Announces Appointment of Directors CI
Chart Welcure Drugs & Pharmaceuticals Limited
More charts
Welcure Drugs and Pharmaceuticals Limited is an India-based company. The Company is engaged in providing services for procurements of order.
More about the company
  1. Stock Market
  2. Equities
  3. WELCURE6 Stock
  4. News Welcure Drugs & Pharmaceuticals Limited
  5. Welcure Drugs and Pharmaceuticals' Net Profit Jumps in Fiscal Q4